Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer

Roumen, R. M. H.; Kuijt, G.P.; Liem, Ing Han

doi:10.1016/j.ejso.2006.08.007

Cited by 52 publications

(19 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Repeat SNB has been used successfully in patients with a local relapse of melanoma and breast cancer [12][13][14]. This study shows that repeat SNB is feasible in locally recurrent penile carcinoma.…”

Section: Discussionmentioning

confidence: 88%

Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma

et al. 2010

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 88%

Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Our literature research totalizes 523 patients in 17 different studies, which included between 2 and 117 patients each (Table 1) [9,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26]. Overall SN was succesfully detected in 365/523 patients (70%).…”

Section: Resultsmentioning

confidence: 99%

Axillary Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma Patients after Previous Axillary Surgery: A Systematic Review

Matter¹,

Romy²,

Boubaker³

et al. 2013

JCT

View full text Add to dashboard Cite

Objective: Sentinel lymph node biopsy (SLNB) is a validated staging technique for breast carcinoma. Some women are exposed to have a second SLNB due to breast cancer recurrence or a second neoplasia (breast or other). Due to modified anatomy, it has been claimed that previous axillary surgery represents a contra-indication to SLNB. Our objective was to analyse the literature to assess if a second SLNB is to be recommended or not. Methods: For the present study, we performed a review of all published data during the last 10 years on patients with previous axilla surgery and second SLNB. Results: Our analysis shows that second SLNB is feasible in 70%. Extra-axillary SNs rate (31%) was higher after radical lymph node dissection (ALND) (60% -84%) than after SLNB alone (14% -65%). Follow-up and complementary ALND following negative and positive second SLNB shows that it is a reliable procedure. Conclusion: The review of literature confirms that SLNB is feasible after previous axillary dissection. Triple technique for SN mapping is the best examination to highlight modified lymphatic anatomy and shows definitively where SLNB must be performed. Surgery may be more demanding as patients may have more frequently extra-axillary SN only, like internal mammary nodes. ALND can be avoided when second SLNB harvests negative SNs. These conclusions should however be taken with caution because of the heterogeneity of publications regarding SLNB and surgical technique.

show abstract

“…Limited data from experimental studies suggest that disruption of lymphatic vessels may only be temporary and a new lymphatic network will be built up by collaterals and retained open lymphatic vessels [10]. Further research is needed to assess exact changes in lymphatic pathways and thus allow a definite statement with regard to the clinical and oncological relevance of secondary lymph node staging [11][12][13][14][15].…”

Section: Introductionmentioning

confidence: 97%

Management of the axilla for ipsilateral breast cancer recurrence after previous sentinel lymph node biopsy and breast conserving therapy

et al. 2010

View full text Add to dashboard Cite

The sentinel lymph node biopsy (SLNB) is the standard procedure for axillary staging in patients with primary breast cancer. Of these patients, 10-15% will develop local breast cancer recurrence. Optimal management of the axilla for these patients is still not established. The aim of this review is to assess the role of secondary lymph node biopsy in patients with ipsilateral breast cancer recurrence. The MED-LINE-PubMed databases were searched from 2006 to 2010 for publications addressing the role of secondary SLNB for ipsilateral breast cancer recurrence. Following terms were used: breast cancer recurrence, sentinel node biopsy, lymphatic drainage, follow-up lymphatic mapping. Twenty-two publications reporting a second SLNB at the time of ipsilateral relapse were identified. The detection rate of a new sentinel node (SN) was 45-97%. The detection rate varied depending on the type of previous surgery. A high rate of extra-axillary re-SN was reported (32%). In 8-35% cases, a histologically positive re-SN was diagnosed. The optimal management of the axilla in the setting of local recurrence is still not established. Prospective trials are needed to facilitate evidence-based recommendations for this situation. Keywords Breast cancer recurrence . Sentinel node biopsy . Follow-up lymphatic mapping . Axillary surgery Abbreviations AGO German Gynecological Oncology ASCO American Society of Clinical Oncology ALND axillary lymph node dissection BCT breast conserving therapy LSG lymphoscintigraphy SLNB sentinel lymph node biopsy SN sentinel node Background

show abstract

Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer

Cited by 52 publications

References 22 publications

Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma

Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma

Axillary Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma Patients after Previous Axillary Surgery: A Systematic Review

Management of the axilla for ipsilateral breast cancer recurrence after previous sentinel lymph node biopsy and breast conserving therapy

Contact Info

Product

Resources

About